Immunologische und Biochemische Diagnostik maligner Tumoren = Diagnostic immunologique et biochimique des tumeurs malignes = Immunological and biochemical diagnosis of malignant tumorsOHLENSCHLÄGER, G; BERGER, I.Labor - Medizin (GIT-Verlag Giebeler). 1984, Vol 7, Num 1, pp 36-41, issn 0170-205XArticle

Quand est-il utile de doser un marqueur tumoral ? : La prescription responsable 2e partie: la biologieMACHIELS, J. P.Louvain médical. 2006, Vol 125, Num 5, issn 0024-6956, S140-S143Conference Paper

The clinical usefulness and limitations of tumor markersTOROSIAN, M. H.Surgery, gynecology & obstetrics. 1988, Vol 166, Num 6, pp 567-579, issn 0039-6087Article

Intérêt du dosage des marqueurs tumoraux = Lesefulness of tumoral markers assayROUX, F; BISSET, J. P.Méditerranée médicale. 1988, Num 379, pp 39-40, issn 0302-9263Conference Paper

Tumour markers: present status and future prospectsBINAY KUMAR.Indian Medical Journal. 1990, Vol 84, Num 12, pp 374-376, issn 0019-5871, 3 p.Article

Ferritin-bearing lymphocytes in patients with cancer = Lymphocytes porteurs de ferritine chez les cancéreuxPAPENHAUSEN, P. R; EMESON, E. E; CROFT, C. B et al.Cancer. 1984, Vol 53, Num 2, pp 267-271, issn 0008-543XArticle

A simple method for the purification of the carcinoembryonic antigen without the use of perchloric acidRITSCHARD, W. J; LE DAIN, M.Experientia. 1983, Vol 39, Num 4, pp 375-377, issn 0014-4754Article

Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule?SAEKI, Norihisa; JIAN GU; YOSHIDA, Teruhiko et al.Clinical cancer research (Print). 2010, Vol 16, Num 14, pp 3533-3538, issn 1078-0432, 6 p.Article

Quality assessment of tumor marker determinations: a proposal for a supraregional schemePIFFANELLI, A; GIGANTI, M; COLAMUSSI, P et al.The International journal of biological markers. 1994, Vol 9, Num 1, pp 48-52, issn 0393-6155Article

6th IRIST meeting : abstracts, Lausanne, March 8-9, 1991The International journal of biological markers. 1991, Vol 6, Num 4, pp 257-264, issn 0393-6155Conference Paper

Biochemical markers of lung cancerTEELING, M. E; CARNEY, D. N.Lung biology in health and disease. 1988, Vol 37, pp 43-58, issn 0362-3181Article

Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9HAGLUND, C; KUUSELA, P; JALANKO, H et al.International journal of cancer. 1987, Vol 39, Num 4, pp 477-481, issn 0020-7136Article

Regional differences in normal and cancer-associated glycoconjugates of the human colonBRESALIER, R. S; BOLAND, C. R; KIM, Y. S et al.Journal of the National Cancer Institute. 1985, Vol 75, Num 2, pp 249-260, issn 0027-8874Article

Urinary catabolites of ribonucleic acid as cancer markers: a preliminary report of their use in patients with lung cancerMACKENZIE, J. W; LEWIS, R. J; SISLER, G. E et al.The Annals of thoracic surgery. 1984, Vol 38, Num 2, pp 133-139, issn 0003-4975Article

Alkaline phosphatase isoenzymes in human cancers = Isoenzymes de la phosphatase alcaline dans les cancers humainsHIGASHINO, K.Gann monograph on cancer research. 1983, Vol 29, pp 251-261, issn 0072-0151Article

Principales localisations tumorales et leurs marqueurs = Principal tumor localizations and their markersROUGIER, P; BELLET, D.Concours médical (Paris). 1983, Num 39, pp 35-43, issn 0010-5309Article

Biochemical and biological markers of neoplastic transformation: [proceedings]/NATO Advanced Study Institute on biochemical and biological markers of neoplastic transformation, Corfu, September 28-October 8, 1981 = Marqueurs biochimiques et biologiques de la transformation néoplasique (comptes rendus)/Institut d'études avancées de l'OTAN sur les marqueurs biochimiques et biologiques de la transformation néoplasique, Corfou, 28 septembre-8 octobre 1981CHANDRA, Prakash.Biochemical and biological markers of neoplastic transformation. Advanced study institute. 1983, XV-639 p, isbn 0-306-41240-3Conference Proceedings

Publication of Tumor Marker Research Results: The Necessity for Complete and Transparent ReportingMCSHANE, Lisa M; HAYES, Daniel F.Journal of clinical oncology. 2012, Vol 30, Num 34, pp 4223-4232, issn 0732-183X, 10 p.Article

Tumor pretargeting : almost the bottom lineGOODWIN, D. A.The Journal of nuclear medicine (1978). 1995, Vol 36, Num 5, pp 876-879, issn 0161-5505Article

The tumor markers TPA, TPS, TPA_CYK and CYFRA 21-1 react differently with the keratins 8, 18 and 19BONDENMÜLLER, H; DONIE, F; KAUFMANN, M et al.The International journal of biological markers. 1994, Vol 9, Num 2, pp 70-74, issn 0393-6155Article

Du bon usage des marqueurs tumoraux. IIROUGIER, P.Concours médical (Paris). 1991, Vol 113, Num 12, pp 981-983, issn 0010-5309Article

Marcadores tumorales = Tumor markersRAMIREZ, H; RODRIGUEZ, J. E; PALACIO, H. M et al.AMC. Acta médica colombiana. 1990, Vol 15, Num 3, pp 153-163, issn 0120-2448, 11 p.Article

Polymerase chain reaction and analysis of cancer cell markersKAWASAKI, E; ERLICH, H.Journal of the National Cancer Institute. 1990, Vol 82, Num 10, pp 806-807, issn 0027-8874Article

Evaluation of a serologic marker, CA19-9, in the diagnosis of pancreatic cancerPLESKOW, D. K; BERGER, H. J; GYVES, J et al.Annals of internal medicine. 1989, Vol 110, Num 9, pp 704-709, issn 0003-4819Article

Cell lineage markers in premalignant and malignant colonic mucosaHO, S. B; ITZKOWITZ, S. H; FRIERA, A. M et al.Gastroenterology (New York, NY. 1943). 1989, Vol 97, Num 2, pp 392-404, issn 0016-5085, 13 p.Article